After the announcement yesterday, Abbott shares edged up 0.6%, finishing at $113.29. The AVEIR leadless pacemaker remains one of the key drivers of the Rhythm Management business. By continuously ...

Abbott has completed the first-in-human procedures for leadless left bundle branch area pacing (LBBAP) using its AVEIR conduction system pacing (CSP) leadless pacemaker system. The investigational ...

MUSKEGON, M I— Trinity Health Muskegon recently achieved a significant milestone by successfully implanting AVEIR DR, the world’s first dual-chamber leadless pacemaker system designed to ...

A Bakersfield hospital Monday became the first in Kern County to successfully implant the AVEIR DR, the world's first dual-chamber leadless pacemaker system from Abbott that treats people with ...